MedPath

PFIZER INC.

PFIZER INC. logo
🇺🇸United States
Ownership
Public
Established
1849-01-01
Employees
88K
Market Cap
$163.3B
Website
http://www.pfizer.com

A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris

Phase 1
Recruiting
Conditions
Acne Vulgaris
Interventions
Drug: PF-07905428
Drug: Placebo
First Posted Date
2024-11-04
Last Posted Date
2024-12-24
Lead Sponsor
Pfizer
Target Recruit Count
52
Registration Number
NCT06671834
Locations
🇨🇦

InnovaDerm, Montreal, Quebec, Canada

🇨🇦

Innovaderm Research Inc., Montréal, Quebec, Canada

A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults

Phase 1
Recruiting
Conditions
Healthy Volunteers
Interventions
Drug: PF-07976016 Formulation A
Drug: PF-07976016 Formulation B
First Posted Date
2024-11-01
Last Posted Date
2024-11-11
Lead Sponsor
Pfizer
Target Recruit Count
12
Registration Number
NCT06670170
Locations
🇺🇸

Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States

A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Healthy Adults

Phase 1
Not yet recruiting
Conditions
Healthy
Interventions
Drug: Treatment A
Drug: Treatment B
Drug: Treatment C
Drug: Treatment D
First Posted Date
2024-10-28
Last Posted Date
2024-11-27
Lead Sponsor
Pfizer
Target Recruit Count
16
Registration Number
NCT06661694
Locations
🇧🇪

Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium

A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults

Phase 1
Recruiting
Conditions
Healthy Participants
Interventions
Drug: PF-06414300
Drug: Placebo
First Posted Date
2024-10-26
Last Posted Date
2024-10-26
Lead Sponsor
Pfizer
Target Recruit Count
61
Registration Number
NCT06659250
Locations
🇺🇸

Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States

ATTR-CM: A Multi-country, Non-interventional Disease Registry

Not yet recruiting
Conditions
Transthyretin Amyloid Cardiopathy
First Posted Date
2024-10-21
Last Posted Date
2024-10-21
Lead Sponsor
Pfizer
Target Recruit Count
350
Registration Number
NCT06651073

Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy

Active, not recruiting
Conditions
Respiratory Syncytial Virus
Respiratory Tract Diseases
Interventions
Biological: ABRYSVO
First Posted Date
2024-10-18
Last Posted Date
2024-10-18
Lead Sponsor
Pfizer
Target Recruit Count
1
Registration Number
NCT06647654
Locations
🇦🇷

Pfizer, Buenos Aires, Argentina

A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults

Phase 1
Recruiting
Conditions
Healthy
Interventions
Drug: ibuzatrelvir
Drug: carbamazepine ER
First Posted Date
2024-10-17
Last Posted Date
2024-11-14
Lead Sponsor
Pfizer
Target Recruit Count
12
Registration Number
NCT06646042
Locations
🇺🇸

Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States

A Study to Learn How Different Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood in Healthy Adults

Phase 1
Recruiting
Conditions
Healthy
Interventions
Drug: single dose of vepdegestrant as tablet formulation (Treatment A)
Drug: single dose of vepdegestrant as tablet formulation (Treatment B)
First Posted Date
2024-10-17
Last Posted Date
2025-01-09
Lead Sponsor
Pfizer
Target Recruit Count
12
Registration Number
NCT06645938
Locations
🇧🇪

Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Phase 3
Not yet recruiting
Conditions
Menstrual Migraine
Interventions
Drug: Rimegepant
Drug: Placebo Comparator
Drug: Standard of Care
First Posted Date
2024-10-15
Last Posted Date
2024-11-07
Lead Sponsor
Pfizer
Target Recruit Count
723
Registration Number
NCT06641466

Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B

Not yet recruiting
Conditions
Hemophilia A
Hemophilia B
First Posted Date
2024-10-10
Last Posted Date
2024-12-18
Lead Sponsor
Pfizer
Target Recruit Count
40
Registration Number
NCT06634836
© Copyright 2025. All Rights Reserved by MedPath